Current Assets

Short- term Investments

Analysis

StatementBalance Sheet Statement
SectionCurrent Assets
First reportedQ3 2025
Last reportedQ1 2026
Metric ID: current_assets_marketable_securities_current

Historical Data

2 periods
 Q4 '25Q1 '26
Value$0.00$375.00M
Range$0.00 – $375.00M

Short- term Investments at Other Companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGNView metric
Gilead Sciences logo
Gilead SciencesGILDView metric
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTXView metric

Frequently Asked Questions

What is Merck & Co.'s short- term investments?
Merck & Co. (MRK) reported short- term investments of $375.00M in Q1 2026.